3M CO Price Risk Derivative Instruments Not Designated as Hedging Instruments Asset, at Fair Value
3M CO (MMM) had Price Risk Derivative Instruments Not Designated as Hedging Instruments Asset, at Fair Value of $1.00 million as of 2009-12-31, per its 8-K filed 2011-05-26.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Summary of Derivative Instruments by Risk Exposure › Price Risk Derivatives
us-gaap:PriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue · last filed 2011-05-26
- 2009-12-31: Price Risk Derivative Instruments Not Designated as Hedging Instruments Asset, at Fair Value $1.00M.
| Period end | Price Risk Derivative Instruments Not Designated as Hedging Instruments Asset, at Fair Value |
|---|---|
| 2009-12-31 | $1.00M 8-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |